FIRSTREGULARSESSION
HOUSECOMMITTEESUBSTITUTEFOR
HOUSEBILLNO.197
102NDGENERALASSEMBLY
0404H.03C DANARADEMANMILLER,ChiefClerk
ANACT
Torepealsections338.015,376.387,and376.388,RSMo,andtoenactinlieuthereofseven
newsectionsrelatingtopaymentsforprescriptiondrugs,withpenaltyprovisions.
BeitenactedbytheGeneralAssemblyofthestateofMissouri,asfollows:
SectionA.Sections338.015,376.387,and376.388,RSMo,arerepealedandseven
2newsectionsenactedinlieuthereof,tobeknownassections103.200,338.015,376.387,
3376.388,376.414,376.687,and376.689,toreadasfollows:
103.200.1.Forpurposesofthissection,thefollowingtermsmean:
2 (1)"Pharmacy",thesamemeaninggiventotheterminsection338.210;
3 (2)"Plan",theMissouriconsolidatedhealthcareplanasdescribedinsection
4103.005;
5 (3)"Rebate",anydiscount,negotiatedconcession,orotherpaymentprovided
6byapharmaceuticalmanufacturer,pharmacy,orhealthbenefitplantoanentitytosell,
7provide,pay,orreimburseapharmacyorotherentityinthestateforthedispensation
8oradministrationofaprescriptiondrugonbehalfofitselforanotherentity.
9 2.BeforeMarch1,2025,andannuallythereafter,thepharmacybenefits
10managerutilizedbytheMissouriconsolidatedhealthcareplanshallfileareportwith
11theplanfortheimmediatelyprecedingcalendaryear.Thereportshallcontainthe
12followinginformationregardingtheplan:
13 (1)Theaggregatedollaramountofallrebatesthatthepharmacybenefits
14managercollectedfrompharmaceuticalmanufacturersthatmanufacturedoutpatient
15prescriptiondrugsthat:
16 (a)Werecoveredbytheplanduringsuchcalendaryear;and
EXPLANATION—Matterenclosedinbold-facedbrackets[thus] intheabovebillisnotenactedandis
intendedtobeomittedfromthelaw.Matterinbold-facetypeintheabovebillisproposedlanguage. 17 (b)Wereattributabletopatientutilizationofsuchdrugsduringsuchcalendar
18year;and
19 (2)Theaggregatedollaramountofallrebates,excludinganyportionofthe
20rebatesreceivedbytheplan,concerningdrugformulariesthatthepharmacybenefits
21managercollectedfrompharmaceuticalmanufacturersthatmanufacturedoutpatient
22prescriptiondrugsthat:
23 (a)Werecoveredbytheplanduringsuchcalendaryear;and
24 (b)Wereattributabletopatientutilizationofsuchdrugsbycoveredpersons
25undertheplanduringsuchcalendaryear.
26 3.Inconsultationwithitspharmacybenefitsmanager,theplanshallestablisha
27formforreportingtheinformationrequiredundersubsection2ofthissection.The
28formshallbedesignedtominimizetheadministrativeburdenandcostofreportingon
29theplananditspharmacybenefitsmanager.
30 4.Nodocuments,materials,orotherinformationsubmittedtotheplanunder
31subsection2ofthissectionshallbesubjecttodisclosureunderchapter610,excepttothe
32extenttheyareincludedonanaggregatedbasisinthereportsrequiredundersubsection
335ofthissection.Theplanshallnotdiscloseinformationsubmittedundersubsection2
34ofthissectioninamannerthat:
35 (1)Islikelytocompromisethefinancial,competitive,orproprietarynatureof
36suchinformation;or
37 (2)Wouldenableathirdpartytoidentifythevalueofarebateprovidedfora
38particularoutpatientprescriptiondrugortherapeuticclassofoutpatientprescription
39drugs.
40 5.(1)BeforeJuly1,2025,andannuallythereafter,theplanshallsubmitareport
41tothestandingcommitteesofthegeneralassemblyhavingjurisdictionoverhealth
42insurancematters.Thereportshallcontainanaggregationoftheinformation
43submittedtotheplanundersubdivision(1)ofsubsection2ofthissectionforthe
44immediatelyprecedingcalendaryearandsuchotherinformationastheplaninits
45discretiondeemsrelevantforthepurposesofthissection.Theplanshallprovideits
46pharmacybenefitsmanagerandanythirdpartyaffectedbysubmissionofareport
47requiredbythissubsectionwithawrittennoticedescribingthecontentofthereport.
48 (2)BeforeJuly1,2025,andannuallythereafter,theplanshallprepareareport
49fortheimmediatelyprecedingcalendaryeardescribingtherebatepracticesoftheplan
50anditspharmacybenefitsmanager.Theplanshallprovidethereporttothestanding
51committeesofthegeneralassemblyhavingjurisdictionoverhealthinsurancematters
52andthedirectorofthedepartmentofcommerceandinsurance.Thereportshall
53contain:
HCSHB197 2 54 (a)Anexplanationofthemannerinwhichtheplanaccountedforrebatesin
55calculatingpremiumsforsuchyear;
56 (b)Astatementdisclosingwhether,anddescribingthemannerinwhich,the
57planmaderebatesavailabletoenrolleesatthepointofpurchaseduringsuchyear;
58 (c)Astatementdescribinganyothermannerinwhichtheplanappliedrebates
59duringsuchyear;and
60 (d)Suchotherinformationastheplaninitsdiscretiondeemsrelevantforthe
61purposesofthissection.
62 6.Theplanmayimposeapenaltyofnomorethanseventhousandfivehundred
63dollarsonitspharmacybenefitsmanagerforeachviolationofthissection.
338.015.1.Theprovisionsofsections338.010to338.015shallnotbeconstruedto
2inhibitthepatient'sfreedomofchoicetoobtainprescriptionservicesfromanylicensed
3pharmacistorpharmacy. [However,nothinginsections338.010to338.315abrogatesthe
4patient'sabilitytowaivefreedomofchoiceunderanycontractwithregardtopaymentor
5coverageofprescriptionexpense.]
6 2.Allpharmacistsmayprovidepharmaceuticalconsultationandadvicetopersons
7concerningthesafeandtherapeuticuseoftheirprescriptiondrugs.
8 3.Allpatientsshallhavetherighttoreceiveawrittenprescriptionfromtheir
9prescribertotaketothefacilityoftheirchoiceortohaveanelectronicprescription
10transmittedtothefacilityoftheirchoice.
11 4.Nopharmacybenefitsmanager,asdefinedinsection376.388,shallprohibitor
12redirectbycontract,orotherwisepenalizeorrestrict,acoveredperson,asdefinedin
13section376.387,fromobtainingprescriptionservices,consultation,oradvicefroma
14contractedpharmacy,asdefinedinsection376.388.
376.387.1.Forpurposesofthissection,thefollowingtermsshallmean:
2 (1)"Coveredperson",[thesamemeaningassuchtermisdefinedinsection376.1257]
3apolicyholder,subscriber,enrollee,orotherindividualwhoreceivesprescriptiondrug
4coveragethroughapharmacybenefitsmanager;
5 (2)"Healthbenefitplan",thesamemeaningassuchtermisdefinedinsection
6376.1350;
7 (3)"Healthcarrier"or"carrier",thesamemeaningassuchtermisdefinedinsection
8376.1350;
9 (4)"Pharmacy",thesamemeaningassuchtermisdefinedinchapter338;
10 (5)"Pharmacybenefitsmanager",thesamemeaningassuchtermisdefinedin
11section376.388.
12 2.Nopharmacybenefitsmanagershallincludeaprovisioninacontractenteredinto
13ormodifiedonorafterAugust28,2018,withapharmacyorpharmacistthatrequiresa
HCSHB197 3 14coveredpersontomakeapaymentforaprescriptiondrugatthepointofsaleinanamount
15thatexceedsthelesserof:
16 (1)Thecopaymentamountasrequiredunderthehealthbenefitplan;or
17 (2)Theamountanindividualwouldpayforaprescriptionifthatindividualpaidwith
18cash.
19 3.Apharmacyorpharmacistshallhavetherighttoprovidetoacoveredperson
20informationregardingtheamountofthecoveredperson'scostshareforaprescriptiondrug,
21thecoveredperson'scostofanalternativedrug,andthecoveredperson'scostofthedrug
22withoutadjudicatingtheclaimthroughthepharmacybenefitsmanager.Neitherapharmacy
23norapharmacistshallbeproscribedbyapharmacybenefitsmanagerfromdiscussingany
24suchinformationorfromsellingamoreaffordablealternativetothecoveredperson.
25 4.Nopharmacybenefitsmanagershall,directlyorindirectly,chargeorholda
26pharmacistorpharmacyresponsibleforanyfeeamountrelatedtoaclaimthatisnotknownat
27thetimeoftheclaim'sadjudication,unlesstheamountisaresultofimproperlypaidclaims
28[orchargesforadministeringahealthbenefitplan].
29 5.[ThissectionshallnotapplywithrespecttoclaimsunderMedicarePartD,orany
30otherplanadministeredorregulatedsolelyunderfederallaw,andtotheextentthissection
31maybepreemptedundertheEmployeeRetirementIncomeSecurityActof1974forself-
32fundedemployer-sponsoredhealthbenefitplans.
33 6.]Apharmacybenefitsmanagershallnotifyinwritinganyhealthcarrierwithwhich
34itcontractsifthepharmacybenefitsmanagerhasaconflictofinterest,anycommonalityof
35ownership,oranyotherrelationship,financialorotherwise,betweenthepharmacybenefits
36managerandanyotherhealthcarrierwithwhichthepharmacybenefitsmanagercontracts.
37 [7.]6.Anyentitythatentersintoacontracttosell,provide,pay,orreimbursea
38pharmacyinthestateforprescriptiondrugsonbehalfofitselforanotherentityshall
39defineandapplytheterm"generic",withrespecttoprescriptiondrugs,tomeanany
40"authorizedgenericdrug",asdefinedin21CFR314.3,approvedundersection505(c)
41oftheFederalFood,Drug,andCosmeticAct,asamended.
42 7.Anyentitythatentersintoacontracttosell,provide,pay,orreimbursea
43pharmacyinthestateforprescriptiondrugsonbehalfofitselforanotherentityshall
44defineandapplytheterm"rebate"ashavingthesamemeaninggiventothetermin
45section103.200.
46 8.Apharmacybenefitsmanagerthathascontractedwithanentitytoprovide
47pharmacybenefitmanagementservicesforsuchanentityshalloweafiduciarydutyto
48thatentity,andshalldischargethatdutyinaccordancewithfederalandstatelaw.
49 9.Thedepartmentofcommerceandinsuranceshallenforcethissection.
HCSHB197 4 376.388.1.Asusedinthissection,unlessthecontextrequiresotherwise,the
2followingtermsshallmean:
3 (1)"Contractedpharmacy"[or"pharmacy"], apharmacylocatedinMissouri
4participatinginthenetworkofapharmacybenefitsmanagerthroughadirectorindirect
5contract;
6 (2)["Healthcarrier",anentitysubjecttotheinsurancelawsandregulationsofthis
7statethatcontractsorofferstocontracttoprovide,deliver,arrangefor,payfor,orreimburse
8anyofthecostsofhealthcareservices,includingasicknessandaccidentinsurancecompany,
9ahealthmaintenanceorganization,anonprofithospitalandhealthservicecorporation,orany
10otherentityprovidingaplanofhealthinsurance,healthbenefits,orhealthservices,except
11thatsuchplanshallnotincludeanycoveragepursuanttoaliabilityinsurancepolicy,workers'
12compensationinsurancepolicy,ormedicalpaymentsinsuranceissuedasasupplementtoa
13liabilitypolicy;
14 (3)] "Maximumallowablecost",theper-unitamountthatapharmacybenefits
15managerreimbursesapharmacistforaprescriptiondrug,excludingadispensingor
16professionalfee;
17 [(4)](3)"Maximumallowablecostlist"or"MAClist",alistingofdrugproductsthat
18meetthestandarddescribedinthissection;
19 [(5)](4)"Pharmacy",assuchtermisdefinedinchapter338;
20 [(6)](5)"Pharmacybenefitsmanager",anentitythat[contractswithpharmacieson
21behalfofhealthcarriersoranyhealthplansponsoredbythestateorapoliticalsubdivisionof
22thestate]administersormanagesapharmacybenefitsplanorprogram;
23 (6)"Pharmacybenefitsmanageraffiliate",apharmacyorpharmacistthat
24directlyorindirectly,throughoneormoreintermediaries,ownsorcontrols,isownedor
25controlledby,orisundercommonownershiporcontrolwithapharmacybenefits
26manager;
27 (7)"Pharmacybenefitsplanorprogram",aplanorprogramthatpaysfor,
28reimburses,coversthecostof,orotherwiseprovidesforprescriptiondrugsand
29pharmacistservicestoindividualswhoresideinorareemployedinthisstate.
30 2.Uponeachcontractexecutionorrenewalbetweenapharmacybenefitsmanager
31andapharmacyorbetweenapharmacybenefitsmanagerandapharmacy'scontracting
32representativeoragent,suchasapharmacyservicesadministrativeorganization,apharmacy
33benefitsmanagershall,withrespecttosuchcontractorrenewal:
34 (1)Includeinsuchcontractorrenewalthesourcesutilizedtodeterminemaximum
35allowablecostandupdatesuchpricinginformationatleasteverysevendays;and
36 (2)Maintainaproceduretoeliminateproductsfromthemaximumallowablecostlist
37ofdrugssubjecttosuchpricingormodifymaximumallowablecostpricingatleastevery
HCSHB197 5 38sevendays,ifsuchdrugsdonotmeetthestandardsandrequirementsofthissection,inorder
39toremainconsistentwithpricingchangesinthemarketplace.
40 3.Apharmacybenefitsmanagershallreimbursepharmaciesfordrugssubjectto
41maximumallowablecostpricingthathasbeenupdatedtoreflectmarketpricingatleastevery
42sevendaysassetforthundersubdivision(1)ofsubsection2ofthissection.
43 4.Apharmacybenefitsmanagershallnotplaceadrugonamaximumallowablecost
44listunlessthereareatleasttwotherapeuticallyequivalentmultisourcegenericdrugs,orat
45leastonegenericdrugavailablefromatleastonemanufacturer,generallyavailablefor
46purchasebynetworkpharmaciesfromnationalorregionalwholesalers.
47 5.(1)Allcontractsbetweenapharmacybenefitsmanagerandacontractedpharmacy
48orbetweenapharmacybenefitsmanagerandapharmacy'scontractingrepresentativeor
49agent,suchasapharmacyservicesadministrativeorganization,shallincludeaprocessto
50internallyappeal,investigate,andresolvedisputesregardingmaximumallowablecost
51pricing.Theprocessshallincludethefollowing:
52 [(1)](a)Therighttoappealshallbelimitedtofourteencalendardaysfollowingthe
53reimbursementoftheinitialclaim;and
54 [(2)](b)Arequirementthatthepharmacybenefitsmanagershallrespondtoan
55appealdescribedinthissubsectionnolaterthanfourteencalendardaysafterthedatethe
56appealwasreceivedbysuchpharmacybenefitsmanager.
57 (2)Ifareimbursementtoacontractedpharmacyisbelowthepharmacy'scostto
58purchasethedrug,thepharmacybenefitsmanagershallsustainanappealandincrease
59reimbursementtothepharmacyandothercontractedpharmaciestocoverthecostof
60purchasingthedrug.
61 (3)Apharmacybenefitsmanagershallnotreimburseapharmacyor
62pharmacistinthestateanamountlessthantheamountthatthepharmacybenefits
63managerreimbursesapharmacybenefitsmanageraffiliateforprovidingthesame
64pharmacistservices.
65 6.Forappealsthataredenied,thepharmacybenefitsmanagershallprovidethe
66reasonforthedenialandidentifythenationaldrugcodeofadrugproductthatmaybe
67purchasedbycontractedpharmaciesatapriceatorbelowthemaximumallowablecostand,
68whenapplicable,maybesubstitutedlawfully.
69 7.Iftheappealissuccessful,thepharmacybenefitsmanagershall:
70 (1)Adjustthemaximumallowablecostpricethatisthesubjectoftheappealeffective
71onthedayafterthedatetheappealisdecided;
72 (2)Applytheadjustedmaximumallowablecostpricetoallsimilarlysituated
73pharmaciesasdeterminedbythepharmacybenefitsmanager;and
HCSHB197 6 74 (3)Allowthepharmacythatsucceededintheappealtoreverseandrebillthe
75pharmacybenefitsclaimgivingrisetotheappeal.
76 8.Appealsshallbeupheldif:
77 (1)Thepharmacybeingreimbursedforthedrugsubjecttothemaximumallowable
78costpricinginquestionwasnotreimbursedasrequiredundersubsection3ofthissection;or
79 (2)Thedrugsubjecttothemaximumallowablecostpricinginquestiondoesnotmeet
80therequirementssetforthundersubsection4ofthissection.
376.414.1.Forpurposesofthissection,thefollowingtermsmean:
2 (1)"340Bdrug",adrugthatis:
3 (a)AcoveredoutpatientdrugasdefinedinSection340BofthePublicHealth
4ServiceAct,42U.S.C.Section256b,enactedbySection602oftheVeteransHealthCare
5Actof1992,Pub.L.102-585;and
6 (b)Purchasedunderanagreemententeredintounder42U.S.C.Section256b;
7 (2)"Coveredentity",thesamemeaninggiventotheterminSection340B(a)(4)
8ofthePublicHealthServiceAct,42U.S.C.Section256b(a)(4);
9 (3)"Healthcarrier",thesamemeaninggiventotheterminsection376.1350;
10 (4)"Pharmacy",anentitylicensedunderchapter338;
11 (5)"Pharmacybenefitsmanager",thesamemeaninggiventotheterminsection
12376.388.
13 2.Ahealthcarrier,pharmacybenefitsmanager,oranagentoraffiliateofsuch
14healthcarrierorpharmacybenefitsmanagershallnotdiscriminateagainstacovered
15entityorapharmacyincluding,butnotlimitedto,anyofthefollowing:
16 (1)Reimbursingacoveredentityorpharmacyforaquantityofa340Bdrugin
17anamountlessthanitwouldpaytoanyothersimilarlysituatedpharmacythatisnota
18coveredentityorapharmacyforsuchquantityofsuchdrugonthebasisthattheentity
19orpharmacyisacoveredentityorpharmacyorthattheentityorpharmacydispenses
20340Bdrugs;
21 (2)Imposinganytermsorconditionsoncoveredentitiesorpharmaciesthat
22differfromsuchtermsorconditionsappliedtoothersimilarlysituatedpharmaciesthat
23arenotcoveredentitiesorpharmaciesonthebasisthattheentityorpharmacyisa
24coveredentityorpharmacyorthattheentityorpharmacydispenses340Bdrugs
25including,butnotlimitedto,termsorconditionswithrespecttoanyofthefollowing:
26 (a)Fees,chargebacks,clawbacks,adjustments,orotherassessments;
27 (b)Professionaldispensingfees;
28 (c)Restrictionsorrequirementsregardingparticipationinstandardor
29preferredpharmacynetworks;
HCSHB197 7 30 (d)Requirementsrelatingtothefrequencyorscopeofauditsortoinventory
31managementsystemsusinggenerallyacceptedaccountingprinciples;and
32 (e)Anyotherrestrictions,conditions,practices,orpoliciesthat,asspecifiedby
33thedirectorofthedepartmentofcommerceandinsurance,interferewiththeabilityofa
34coveredentitytomaximizethevalueofdiscountsprovidedunder42U.S.C.Section
35256b;
36 (3)Interferingwithanindividual'schoicetoreceivea340Bdrugfromacovered
37entityorpharmacy,whetherinpersonorviadirectdelivery,mail,orotherformof
38shipmentbyanymeansincluding,butnotlimitedto,modifyingapatient'spayment
39limitationsorcost-sharingobligationsonthebasisofparticipation,inwholeorinpart,
40inthe340Bdrugpricingprogram;
41 (4)Requiringacoveredentityorpharmacytoidentify,eitherdirectlyor
42throughathirdparty,340Bdrugs;
43 (5)Refusingtocontractwithacoveredentityorpharmacyforreasonsother
44thanthosethatapplyequallytoentitiesorpharmaciesthatarenotcoveredentitiesor
45pharmacies,oronthebasisthat:
46 (a)Theentityorpharmacyisacoveredentityorapharmacy;or
47 (b)Theentityorpharmacyisdescribedinanyofsubparagraphs(A)to(O)of42
48U.S.C.Section256b(a)(4);
49 (6)Denyingthecoveredentitytheabilitytopurchasedrugsat340Bprogram
50pricingbysubstitutingarebatediscount;
51 (7)Refusingtocoverdrugspurchasedunderthe340Bdrugpricingprogram;or
52 (8)Requiringacoveredentityorcontractpharmacytoreverse,resubmit,or
53clarifya340B-drugpricingclaimaftertheinitialadjudicationunlesstheseactionsare
54inthenormalcourseofpharmacybusinessandnotrelatedto340Bdrugpricing.
55 3.Thedirectorofthedepartmentofcommerceandinsuranceshallimposea
56civilpenaltyonanyhealthcarrier,pharmacybenefitsmanager,oranagentoraffiliate
57ofsuchhealthcarrierorpharmacybenefitsmanagerthatviolatestherequirementsof
58thissection.Suchpenaltyshallnotexceedfivethousanddollarsperviolationperday.
59 4.Thedirectorofthedepartmentofcommerceandinsuranceshallpromulgate
60rulestoimplementtheprovisionsofthissection.Anyruleorportionofarule,asthat
61termisdefinedinsection536.010,thatiscreatedundertheauthoritydelegatedinthis
62sectionshallbecomeeffectiveonlyifitcomplieswithandissubjecttoallofthe
63provisionsofchapter536and,ifapplicable,section536.028.Thissectionandchapter
64536arenonseverableandifanyofthepowersvestedwiththegeneralassembly
65pursuanttochapter536toreview,todelaytheeffectivedate,ortodisapproveandannul
HCSHB197 8 66arulearesubsequentlyheldunconstitutional,thenthegrantofrulemakingauthority
67andanyruleproposedoradoptedafterAugust28,2023,shallbeinvalidandvoid.
376.687.1.Asusedinthissection,"prescriptioninsulindrug"meansa
2prescriptiondrugthatcontainsinsulinandisusedtocontrolbloodglucoselevelsto
3treatdiabetes,butdoesnotincludeaninsulindrugthatisadministeredtoapatient
4intravenously.
5 2.Thissectionappliestoanygrouporindividualpolicyofaccidentandhealth
6insuranceamended,delivered,issued,orrenewedonorafterAugust28,2023.
7 3.Aninsurerthatprovidescoverageforprescriptioninsulindrugsunderthe
8termsofahealthcoverageplantheinsureroffersshalllimitthetotalamountthatan
9insuredisrequiredtopayforathirty-daysupplyofcoveredprescriptioninsulindrugs
10atanamountnottoexceedseventy-fivedollars,regardlessofthequantityortypeof
11coveredprescriptioninsulindrugusedtofilltheinsured'sprescription.
12 4.OnJanuaryfirstofeachyear,thelimitontheamountthataninsuredis
13requiredtopayforathirty-daysupplyofacoveredprescriptioninsulindrugshall
14increasebyapercentageequaltothepercentagechangefromtheprecedingyearinthe
15medicalcarecomponentoftheConsumerPriceIndexoftheBureauofLaborStatistics
16oftheUnitedStatesDepartmentofLabor.
17 5.Thedirectorofthedepartmentofcommerceandinsurancemaypromulgate
18allnecessaryrulesandregulationsfortheadministrationofthissection.Anyruleor
19portionofarule,asthattermisdefinedinsection536.010,thatiscreatedunderthe
20authoritydelegatedinthissectionshallbecomeeffectiveonlyifitcomplieswithandis
21subjecttoalloftheprovisionsofchapter536and,ifapplicable,section536.028.This
22sectionandchapter536arenonseverableandifanyofthepowersvestedwiththe
23generalassemblypursuanttochapter536toreview,todelaytheeffectivedate,orto
24disapproveandannularulearesubsequentlyheldunconstitutional,thenthegrantof
25rulemakingauthorityandanyruleproposedoradoptedafterAugust28,2023,shallbe
26invalidandvoid.
376.689.1.BeforeNovember2,2023,thedepartmentofcommerceand
2insurance,inconjunctionwiththedepartmentofhealthandseniorservicesandthe
3departmentofsocialservices,shallmakeavailabletothepublicareportthatdetails
4eachdepartment'sfindingsforthefollowing:
5 (1)Asummaryofinsulinpricingpracticesandvariablesthatcontributetothe
6pricingofhealthcoverageplans;
7 (2)Publicpolicyrecommendationstocontrolandpreventoverpricingof
8prescriptioninsulindrugsmadeavailabletoMissouriconsumers;and
HCSHB197 9 9 (3)Anyotherinformationthatthedepartmentofcommerceandinsurancefinds
10necessary.
11 2.TheprovisionsofthissectionterminateonJanuary1,2024.
âś”
HCSHB197 10